166 related articles for article (PubMed ID: 3552348)
21. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
[TBL] [Abstract][Full Text] [Related]
22. Thiotepa, busulfan, and cyclophosphamide as a preparative regimen for allogeneic transplantation for advanced myelodysplastic syndrome and acute myelogenous leukemia.
Bibawi S; Abi-Said D; Fayad L; Anderlini P; Ueno NT; Mehra R; Khouri I; Giralt S; Gajewski J; Donato M; Claxton D; Braunschweig I; van Besien K; Andreeff M; Andersson BS; Estey EH; Champlin R; Przepiorka D
Am J Hematol; 2001 Aug; 67(4):227-33. PubMed ID: 11443634
[TBL] [Abstract][Full Text] [Related]
23. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation from HLA-identical siblings as first-line treatment in patients with myelodysplastic syndromes: early transplantation is associated with improved outcome. Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Runde V; de Witte T; Arnold R; Gratwohl A; Hermans J; van Biezen A; Niederwieser D; Labopin M; Walter-Noel MP; Bacigalupo A; Jacobsen N; Ljungman P; Carreras E; Kolb HJ; Aul C; Apperley J
Bone Marrow Transplant; 1998 Feb; 21(3):255-61. PubMed ID: 9489648
[TBL] [Abstract][Full Text] [Related]
25. [Diagnosis and therapy strategy in myelodysplastic syndromes].
Gattermann N; Aul C
Praxis (Bern 1994); 1996 Jan; 85(3):39-44. PubMed ID: 8578048
[TBL] [Abstract][Full Text] [Related]
26. [Differentiation therapy for myelodysplastic syndrome].
Hino K; Nakamaki T
Rinsho Ketsueki; 1993 Mar; 34(3):283-8. PubMed ID: 7683064
[TBL] [Abstract][Full Text] [Related]
27. Autologous stem cell transplantation in myelodysplastic syndromes.
de Witte T; Suciu S; Brand R; Muus P; Kröger N
Semin Hematol; 2007 Oct; 44(4):274-7. PubMed ID: 17961727
[TBL] [Abstract][Full Text] [Related]
28. Advances in supportive care of myelodysplastic syndromes.
Gordon MS
Semin Hematol; 1999 Oct; 36(4 Suppl 6):21-4. PubMed ID: 10530713
[TBL] [Abstract][Full Text] [Related]
29. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML.
Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC
Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773
[TBL] [Abstract][Full Text] [Related]
30. Unrelated bone marrow transplantation in patients with myelodysplastic syndromes and secondary acute myeloid leukemia: an EBMT survey. European Blood and Marrow Transplantation Group.
Arnold R; de Witte T; van Biezen A; Hermans J; Jacobsen N; Runde V; Gratwohl A; Apperley JF
Bone Marrow Transplant; 1998 Jun; 21(12):1213-6. PubMed ID: 9674854
[TBL] [Abstract][Full Text] [Related]
31. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
[TBL] [Abstract][Full Text] [Related]
32. [Study on the transformation from myelodysplastic syndromes into acute leukemias].
Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096
[TBL] [Abstract][Full Text] [Related]
33. Nursing care of the patient receiving subcutaneous low-dose Ara-C therapy.
Sticklin LA; Dubbelde K; Larson E
Oncol Nurs Forum; 1989; 16(3):365-9. PubMed ID: 2734216
[TBL] [Abstract][Full Text] [Related]
34. [Myeloproliferative syndromes].
Ganser A
Ther Umsch; 1996 Feb; 53(2):97-102. PubMed ID: 8629270
[TBL] [Abstract][Full Text] [Related]
35. Myelodysplastic syndromes: a review for nurses.
Cain J; Hood-Barnes J; Spangler J
Oncol Nurs Forum; 1991; 18(1):113-7. PubMed ID: 2003103
[TBL] [Abstract][Full Text] [Related]
36. [Clinical investigation of interferons in the preleukemic state (CML and MDS)].
Koyama S
Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-2):1191-7. PubMed ID: 3132893
[TBL] [Abstract][Full Text] [Related]
37. Myelodysplastic syndrome.
Hofmann WK; Koeffler HP
Annu Rev Med; 2005; 56():1-16. PubMed ID: 15660498
[TBL] [Abstract][Full Text] [Related]
38. [Current treatment options for myelodysplastic syndromes].
Nolte F; Hofmann WK
Dtsch Med Wochenschr; 2010 Sep; 135(38):1863-9. PubMed ID: 20842606
[No Abstract] [Full Text] [Related]
39. Preleukaemia and myelodysplastic syndromes today.
Jacobs A
Recenti Prog Med; 1989 Oct; 80(10):501-7. PubMed ID: 2690216
[TBL] [Abstract][Full Text] [Related]
40. Complications and treatment of the myelodysplastic syndromes.
Tricot GJ
Leuk Res; 1992; 16(1):117-21. PubMed ID: 1732664
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]